申请人:CHEMOCENTRYX, INC.
公开号:US20220153733A1
公开(公告)日:2022-05-19
Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (Ia1′):
and are useful in pharmaceutical compositions, methods or the treatment of diseases and disorders involving the pathologic activation of CCR2 receptors.